Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2021

01-08-2021 | Venous Thrombosis | Case Report

Homozygous Factor V Leiden presenting as irreversible chronic colon ischemia resulting from inferior mesenteric vein thrombosis

Authors: Kevin Zheng, Lawrence J. Brandt, Darlene LeFrancois

Published in: Clinical Journal of Gastroenterology | Issue 4/2021

Login to get access

Abstract

A 42-year-old man presented with 6 months of unexplained left lower quadrant abdominal pain and hematochezia accompanied by weight loss despite extensive evaluations. Stool studies for pathogens were unrevealing, but an abdominal contrast-enhanced computed tomography revealed findings of chronic inferior mesenteric vein thrombosis. Colonoscopy demonstrated ulcerated strictures and gangrene confined to the sigmoid and descending colons, and biopsies confirmed changes of chronic irreversible colon ischemia. A homozygous Factor V Leiden mutation was diagnosed. The patient underwent colectomy and was treated with lifelong anticoagulation. While mesenteric venous thrombosis is a well-recognized cause of colon ischemia in hypercoagulable states, thrombosis of the inferior mesenteric vein is uncommon; when chronic it is rarely clinically apparent. Similarly, while Factor V Leiden mutation is a common hereditary thrombophilia, it uncommonly causes mesenteric venous thrombosis, and homozygotes of the mutation typically present earlier in the fourth decade and with non-mesenteric venous thromboembolism. This case is valuable and adds to the existing literature in describing a rare, clinically atypical, and late index presentation of homozygous Factor V Leiden mutation as chronic inferior mesenteric vein thrombosis yielding irreversible colon ischemia.
Literature
1.
go back to reference Cotter TG, Bledsoe AC, Sweetser S. Colon ischemia: an update for clinicians. Mayo Clin Proc. 2016;91:671–7.CrossRef Cotter TG, Bledsoe AC, Sweetser S. Colon ischemia: an update for clinicians. Mayo Clin Proc. 2016;91:671–7.CrossRef
2.
go back to reference Harnik IG, Brandt LJ. Mesenteric venous thrombosis. Vasc Med. 2010;15:407–18.CrossRef Harnik IG, Brandt LJ. Mesenteric venous thrombosis. Vasc Med. 2010;15:407–18.CrossRef
3.
go back to reference Bontempo FA, Hassett AC, Faruki H, et al. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation. J Vasc Surg. 1997;25:271–6.CrossRef Bontempo FA, Hassett AC, Faruki H, et al. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation. J Vasc Surg. 1997;25:271–6.CrossRef
4.
go back to reference Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504–8.CrossRef Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85:1504–8.CrossRef
5.
go back to reference Brandt LJ, Feuerstadt P, Longstreth GF, et al. ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia. Am J Gastroenterol. 2015;110:18–44.CrossRef Brandt LJ, Feuerstadt P, Longstreth GF, et al. ACG clinical guideline: epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia. Am J Gastroenterol. 2015;110:18–44.CrossRef
6.
go back to reference Feuerstadt P, Brandt LJ. Update on colon ischemia: recent insights and advances. Curr Gastroenterol Rep. 2015;17:45.CrossRef Feuerstadt P, Brandt LJ. Update on colon ischemia: recent insights and advances. Curr Gastroenterol Rep. 2015;17:45.CrossRef
7.
go back to reference Alschibaja T, Morson BC. Ischaemic bowel disease. J Clin Pathol Suppl (R Coll Pathol). 1977;11:68–77.CrossRef Alschibaja T, Morson BC. Ischaemic bowel disease. J Clin Pathol Suppl (R Coll Pathol). 1977;11:68–77.CrossRef
8.
go back to reference Walker AM, Bohn RL, Cali C, et al. Risk factors for colon ischemia. Am J Gastroenterol. 2004;99:1333–7.CrossRef Walker AM, Bohn RL, Cali C, et al. Risk factors for colon ischemia. Am J Gastroenterol. 2004;99:1333–7.CrossRef
9.
go back to reference Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. 2001;345:1683–8.CrossRef Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. 2001;345:1683–8.CrossRef
10.
go back to reference Vietti Violi N, Fournier N, Duran R, et al. Acute mesenteric vein thrombosis: factors associated with evolution to chronic mesenteric vein thrombosis. AJR Am J Roentgenol. 2014;203:54–61.CrossRef Vietti Violi N, Fournier N, Duran R, et al. Acute mesenteric vein thrombosis: factors associated with evolution to chronic mesenteric vein thrombosis. AJR Am J Roentgenol. 2014;203:54–61.CrossRef
11.
go back to reference Koser T, Rosendaal FR, de Ronde H, et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503–6.CrossRef Koser T, Rosendaal FR, de Ronde H, et al. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503–6.CrossRef
12.
go back to reference Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133–4.CrossRef Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133–4.CrossRef
13.
go back to reference Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912–7.CrossRef Ridker PM, Hennekens CH, Lindpaintner K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912–7.CrossRef
14.
go back to reference Koutroubakis IE, Sfiridaki A, Theodoropoulou A, et al. Role of acquired and hereditary thrombotic risk factors in colon ischemia of ambulatory patients. Gastroenterology. 2001;121:561–5.CrossRef Koutroubakis IE, Sfiridaki A, Theodoropoulou A, et al. Role of acquired and hereditary thrombotic risk factors in colon ischemia of ambulatory patients. Gastroenterology. 2001;121:561–5.CrossRef
15.
go back to reference Chin BW, Greenberg D, Wilson RB, et al. A case of ischemic colitis associated with factor V Leiden mutation: successful treatment with anticoagulation. Gastrointest Endosc. 2007;66:416–8.CrossRef Chin BW, Greenberg D, Wilson RB, et al. A case of ischemic colitis associated with factor V Leiden mutation: successful treatment with anticoagulation. Gastrointest Endosc. 2007;66:416–8.CrossRef
16.
go back to reference Heyn J, Buhmann S, Ladurner R, et al. Recurrent ischemic colitis in a patient with Leiden factor V mutation and systemic lupus erythematous with antiphospholipid syndrome. Eur J Med Res. 2008;13:182–4.PubMed Heyn J, Buhmann S, Ladurner R, et al. Recurrent ischemic colitis in a patient with Leiden factor V mutation and systemic lupus erythematous with antiphospholipid syndrome. Eur J Med Res. 2008;13:182–4.PubMed
17.
go back to reference Silverman M, Aroniadis OC, Feuerstadt P, et al. Older patients are significantly more likely to have colon ischaemia-associated conditions that are chronic and complex. Aliment Pharmacol Ther. 2019;49:1502–8.CrossRef Silverman M, Aroniadis OC, Feuerstadt P, et al. Older patients are significantly more likely to have colon ischaemia-associated conditions that are chronic and complex. Aliment Pharmacol Ther. 2019;49:1502–8.CrossRef
Metadata
Title
Homozygous Factor V Leiden presenting as irreversible chronic colon ischemia resulting from inferior mesenteric vein thrombosis
Authors
Kevin Zheng
Lawrence J. Brandt
Darlene LeFrancois
Publication date
01-08-2021
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 4/2021
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01440-4

Other articles of this Issue 4/2021

Clinical Journal of Gastroenterology 4/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine